Behavioral Nudge for Increasing Colon Cancer Screening Rates
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special pamphlet can encourage more people to complete their colon cancer screening using the FIT test, which checks for hidden blood in stool. The trial will evaluate different pamphlet versions, including one with a social norm driver—a behavioral nudge—showing how the clinic's screening rates compare to state and national goals. Ideal participants are patients aged 45-75 who visit Bellevue Ambulatory Care Resident Clinic, have not completed a FIT test in the past year, and can read English or Spanish. As an unphased trial, this study allows participants to contribute to innovative strategies that may enhance public health screening practices.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on increasing colon cancer screening rates, so it's unlikely that your medications will be affected.
What prior data suggests that this behavioral nudge is safe for increasing colon cancer screening rates?
Research has shown that using educational pamphlets and messages about social norms is generally safe. These methods have been tested in various situations to improve health habits, such as increasing cancer screening participation. Without physical treatment, the risk of side effects remains low. People have used these educational tools without encountering serious problems. The pamphlet provides clear information, while the social norm message encourages participation by highlighting others' actions. These tools are well-received and focus on providing information rather than medical treatment.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to boost colon cancer screening rates, which is crucial for early detection and treatment. Unlike the traditional method of simply handing out a FIT kit, this trial tests the impact of adding an informative pamphlet and a social norm driver. The pamphlet simplifies the screening process with clear instructions and emphasizes its importance, potentially increasing compliance. The social norm driver uniquely motivates patients by showing how the clinic’s screening rates stack up against state and national goals, encouraging participation through a sense of collective responsibility. This approach could significantly improve screening rates by appealing to patients' understanding and community involvement.
What evidence suggests that this behavioral nudge is effective for increasing colon cancer screening rates?
Research has shown that social norms can increase the number of people who complete health screenings, such as the fecal immunochemical test (FIT) for colorectal cancer. In this trial, participants in the "Time Period 3" arm will receive a pamphlet that uses this concept by displaying the clinic's screening rate alongside state and national goals, motivating individuals to complete their tests. Additionally, participants in the "Time Period 2" and "Time Period 3" arms will receive pamphlets with clear instructions and emphasize the importance of FIT screening to help overcome obstacles and boost participation. Overall, these strategies aim to encourage more people to complete their colorectal cancer screenings.678910
Who Is on the Research Team?
Aasma Shaukat, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for individuals aged 45-75 who are due for colorectal cancer screening at Bellevue Hospital Medicine Ambulatory Care Clinic. Details like age, gender, previous screenings, and clinic visits may influence participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Time Period 1
A FIT test is ordered by the provider and a patient care assistant gives the patient a FIT kit at the end of the visit.
Time Period 2
Participants receive a new information pamphlet alongside the FIT kit at the end of the visit.
Time Period 3
Participants receive a new information pamphlet with a social norm driver alongside the FIT kit.
Follow-up
Participants are monitored for completion of their FIT screening test up until 3 months after the initial stool study was given.
What Are the Treatments Tested in This Trial?
Interventions
- Information pamphlet + social norm driver
Trial Overview
The study tests if a 'social norm driver'—a type of behavioral nudge when added to an information pamphlet—increases the rate and speed at which people complete fecal immunochemical tests (FIT) for colon cancer screening.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
A new information pamphlet is given to participants along the FIT kit similar to "Time period 2", but includes a social norm driver in the pamphlet that displays the sub-par screening rate of our clinic compared to a collective New York State screening rate and a national screening rate goal set by the Centers for Disease Control and Prevention (CDC).
A new information pamphlet is given to participants alongside the FIT kit at the end of the visit. The pamphlet contains an easy-to-read description of FIT screening adapted from the NYC department of health C5 Colorectal cancer (CRC) screening coalition pamphlet and lead-time CRC screening messaging tool, instructions on how to complete the test and the importance of FIT screening.
A FIT test is ordered by the provider and a patient care assistant (PCA) gives patient a FIT kit, which includes a specimen cup and instructions on how to use it, at the end of the visit prior to their departure.
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Published Research Related to This Trial
Citations
Colorectal Cancer Screening and Social Needs
Respondents with financial strain, social isolation, and food insecurity had lower odds of being up to date with CRC screening.
Barriers and facilitators of colorectal cancer screening ...
Despite clear evidence that regular screening reduces colorectal cancer (CRC) mortality and the availability of multiple effective screening options, CRC ...
Shared Decision Making in Colorectal Cancer Screening
Survey to examine the correlations between family support and influence, cultural identity, CRC beliefs, and their relationship to an informed decision about ...
4.
frontiersin.org
frontiersin.org/journals/behavioral-economics/articles/10.3389/frbhe.2025.1566172/fullThe impact of dynamic social norms messages on ...
In this study, we aimed to determine if dynamic social norms could increase the intention to complete a FIT, a non-invasive screening test ...
Framework and Strategies to Eliminate Disparities in ...
This paper summarizes the evidence on disparities in CRC health outcomes and discusses a health equity framework to guide the use of evidence-based ...
Colorectal Cancer (CRC) Community Education Toolkit
Colorectal Cancer screening is essential and should not be delayed. Colorectal Cancer is one of the most preventable types of cancer. Based on evidence-based ...
Educational Materials
A longer version of the popular informational 4×6 card, this flyer walks patients through colorectal cancer screening guidelines, screening options, and signs ...
Colorectal Cancer Screening Guidelines
The American Cancer Society 2018 guideline for colorectal cancer screening recommends that average-risk adults aged 45 years and older undergo regular screening ...
Colorectal Cancer Communication Resources
CDC offers resources to help you learn about the importance of men and women 45 years old or older getting screened for colorectal (colon) cancer regularly.
E-mail to Promote Colorectal Cancer Screening Within Social ...
Peer modeling and communication of subjective norms among family and friends have been shown to influence CRC screening rates, particularly in minority and ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.